2013
DOI: 10.1124/mol.112.081935
|View full text |Cite
|
Sign up to set email alerts
|

Vesnarinone Suppresses TNFα mRNA Expression by Inhibiting Valosin-Containing Protein

Abstract: Vesnarinone is a synthetic quinolinone derivative used in the treatment of cardiac failure and cancer. It is also known to cause agranulocytosis as a side effect, which restricts its use, although the mechanism underlying agranulocytosis is not well understood. Here, we show that vesnarinone binds to valosin-containing protein (VCP), which interacts with polyubiquitinated proteins and is essential for the degradation of IkBa to activate nuclear factor (NF)kB. We show that vesnarinone impairs the degradation of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 33 publications
0
4
0
Order By: Relevance
“…Meanwhile, the pharmacological modulation of VCP may reduce motorneuron-toxicity TDP-43-mediate and thus represents a therapeutic strategy for ALS (Supplementary Table 9). In this regard, some VCP inhibitors (Vesnarinone, Xanthohumol) [139,140] have demonstrated to prevent neuroinflammation and apoptosis associated with several neurological diseases [141,142].…”
Section: Vcpmentioning
confidence: 99%
“…Meanwhile, the pharmacological modulation of VCP may reduce motorneuron-toxicity TDP-43-mediate and thus represents a therapeutic strategy for ALS (Supplementary Table 9). In this regard, some VCP inhibitors (Vesnarinone, Xanthohumol) [139,140] have demonstrated to prevent neuroinflammation and apoptosis associated with several neurological diseases [141,142].…”
Section: Vcpmentioning
confidence: 99%
“…Pentoxifylline blocks the TNF-α release in microglia, however, it no effect on the accumulation of nitrites. On the other hand, Vesnarinone inhibits IL-1, IL-6, and TNF-α but no effect on IL-10 (Xie et al, 2002;Chen et al, 2003;Koyama et al, 2010;Hotta et al, 2013). In addition to the above effects, ibudilast also increases IL-10, which also increases IL-1, IL-6, and TNF-α (Stenvinkel et al, 2005) and it seems to have a stronger performance in protecting neurons against damage in neurodegenerative diseases.…”
Section: Discussionmentioning
confidence: 99%
“…The beads with a moderately hydrophilic GMA surface exhibit a low non-specific protein binding and a high binding capacity, due to the small size with a diameter of approximately 200 nm. A wide variety of target proteins for pharmaceutical drugs, environmental hormones, and biologically active compounds have been isolated by using FG beads (Hotta et al, 2013;Ito et al, 2012;Kabe et al, 2016Kabe et al, , 2020. CRBN and damaged specific DNA binding protein 1 (DDB1) were isolated from HeLa cell extracts by affinity purification using FG beads to which FR259625, a carboxy derivative of thalidomide, was immobilized (Figure 2).…”
Section: Crbn As a Direct Target Of Thalidomidementioning
confidence: 99%